EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer

Elmer Joel Millan-Casarrubias iD, Yunia Verónica García-Tejeda iD, Claudia Haydée González-De la Rosa iD, Lucero Ruiz-Mazón iD, Yazmín Mariela Hernández-Rodríguez, Oscar Eduardo Cigarroa-Mayorga iD

Current Issues in Molecular Biology · 15.03.2025 · 47 (3) · 193

DOI: 10.3390/cimb47030193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 15.03.2025. Verfasst von Elmer Joel Millan-Casarrubias und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Mexico City 07340, Mexico. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Politécnico Nacional, Secretaría de Investigación y Posgrado del Instituto Politécnico Nacional (SIP-IPN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is one of the leading causes of cancer-related mortality in women worldwide, highlighting the importance of effective therapies. This study evaluates the interaction between camptothecin, a potent anticancer agent, and two key receptors implicated in breast cancer progression: HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor), using molecular docking. The results reveal a stronger binding affinity between camptothecin and HER2 than EGFR, in contrast to neratinib, which demonstrated affinity exclusively for HER2. Camptothecin exhibits significant hydrophobic and pi-alkyl interactions with HER2, whereas its interactions with EGFR are primarily mediated by hydrogen bonds. Molecular dynamics (MD) simulations of the camptothecin-HER2 complex indicate stable binding, with minimal fluctuations observed over 100 nanoseconds, confirming the stability of the ligand–receptor interaction. Pharmacokinetic evaluations, based on Lipinski’s rule of five, demonstrate that camptothecin adheres to essential drug-likeness parameters, suggesting favorable bioavailability. Furthermore, the analysis comparing the pharmacological properties of camptothecin with other well-known anticancer compounds, such as neratinib, shows that camptothecin exhibited superior compliance with drug-likeness rules. Despite its low solubility, the binding stability and pharmacokinetic profile suggest its potential as an effective therapeutic agent for breast cancer, particularly when combined with drug delivery systems that enhance solubility. This work underscores the importance of receptor-specific ligand interactions in drug design and highlights the need for further studies into camptothecin’s clinical applications, especially in HER2-positive breast cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

EGFRHER2breast cancercamptothecinmolecular dockingpharmacokinetics

Autor:innen und Institutionen

  • Department of Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Mexico City 07340, Mexico.
  • Departamento de Ciencias Naturales, Unidad Cuajimalpa, Universidad Autonóma Metropolitana, Mexico City 05348, Mexico.
  • Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City 07360, Mexico.

ORCID-Profile: Elmer Joel Millan-Casarrubias, Yunia Verónica García-Tejeda, Claudia Haydée González-De la Rosa, Lucero Ruiz-Mazón, Oscar Eduardo Cigarroa-Mayorga

Förderung

  • Instituto Politécnico Nacional
  • Secretaría de Investigación y Posgrado del Instituto Politécnico Nacional (SIP-IPN)

Zitieren

APA

Millan-Casarrubias, E. J., García-Tejeda, Y. V., González-De la Rosa, C. H., Ruiz-Mazón, L., Hernández-Rodríguez, Y. M., & Cigarroa-Mayorga, O. E. (2025). Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer. Current Issues in Molecular Biology, 47(3), 193. https://doi.org/10.3390/cimb47030193

Vancouver

Millan-Casarrubias EJ, García-Tejeda YV, González-De la Rosa CH, Ruiz-Mazón L, Hernández-Rodríguez YM, Cigarroa-Mayorga OE. Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer. Current Issues in Molecular Biology. 2025;47(3):193. doi:10.3390/cimb47030193

BibTeX
@article{MillanCasarrubias2025,
  author = {Millan-Casarrubias, Elmer Joel and García-Tejeda, Yunia Verónica and González-De la Rosa, Claudia Haydée and Ruiz-Mazón, Lucero and Hernández-Rodríguez, Yazmín Mariela and Cigarroa-Mayorga, Oscar Eduardo},
  title = {Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {3},
  pages = {193},
  doi = {10.3390/cimb47030193}
}
Kostenlos starten →